AKCEA THERAPEUTICS INC's ticker is AKCA and the CUSIP is 00972L107. A total of 65 filers reported holding AKCEA THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 1.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $16,494,000 | -37.1% | 1,071,686 | -4.2% | 0.00% | -33.3% |
| Q2 2019 | $26,237,000 | -17.1% | 1,118,858 | +0.2% | 0.01% | -14.3% |
| Q1 2019 | $31,630,000 | -6.2% | 1,116,501 | -0.2% | 0.01% | -12.5% |
| Q4 2018 | $33,711,000 | -45.7% | 1,118,481 | -37.0% | 0.01% | -38.5% |
| Q3 2018 | $62,124,000 | +0.6% | 1,773,972 | -31.9% | 0.01% | -7.1% |
| Q2 2018 | $61,754,000 | -28.7% | 2,604,557 | -23.0% | 0.01% | -30.0% |
| Q1 2018 | $86,667,000 | +78.7% | 3,384,101 | +21.1% | 0.02% | +81.8% |
| Q4 2017 | $48,500,000 | -45.6% | 2,793,822 | -13.3% | 0.01% | -45.0% |
| Q3 2017 | $89,205,000 | – | 3,223,888 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bellevue Group AG | 3,162,643 | $53,575,000 | 0.85% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,723 | $536,000 | 0.19% |
| Amia Capital LLP | 28,217 | $478,000 | 0.14% |
| Motley Fool Asset Management LLC | 60,489 | $1,025,000 | 0.11% |
| Virtus ETF Advisers LLC | 33,059 | $560,000 | 0.09% |
| ALTRINSIC GLOBAL ADVISORS LLC | 70,286 | $1,191,000 | 0.05% |
| A.R.T. Advisors, LLC | 53,560 | $907,000 | 0.04% |
| TUDOR INVESTMENT CORP ET AL | 46,433 | $787,000 | 0.04% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |
| Caption Management, LLC | 54,000 | $915,000 | 0.03% |